Cargando…

Phosphodiesterase-III Inhibitors Amrinone and Milrinone on Epilepsy and Cardiovascular Activities

Detalles Bibliográficos
Autor principal:	Asif, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482785/ https://www.ncbi.nlm.nih.gov/pubmed/23112975 http://dx.doi.org/10.4103/1947-2714.102001

Ejemplares similares

Enhancing Oocyte Competence With Milrinone as a Phosphodiesterase 3A Inhibitor to Improve the Development of Porcine Cloned Embryos
por: Roy, Pantu Kumar, et al.
Publicado: (2021)

Inhibition of cAMP phosphodiesterase by milrinone improves cardiac recovery after deep hypothermic circulatory arrest
por: Troitzsch, D, et al.
Publicado: (2001)

The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
por: Levijoki, Jouko, et al.
Publicado: (2022)

Effects of Inotropic Drugs on Mechanical Function and Oxygen Balance in Postischemic Canine Myocardium: Comparison of Dobutamine, Epinephrine, Amrinone, and Calcium Chloride
por: Yoo, Kyung Yeon, et al.
Publicado: (2005)

Milrinone: Is Bolus Bad?
por: Kulkarni, Venugopal
Publicado: (2018)

Pretreatment with a Phosphodiesterase-3 Inhibitor, Milrinone, Reduces Hepatic Ischemia-Reperfusion Injury, Minimizing Pericentral Zone-Based Liver and Small Intestinal Injury in Rats
por: Nakanuma, Shinichi, et al.
Publicado: (2020)

Milrinone or dobutamine in patients with heart failure: evidence from meta‐analysis
por: Szarpak, Lukasz, et al.
Publicado: (2022)

Clinical implication of ambulatory milrinone therapy in patients with advanced heart failure
por: Nakagawa, Yuri, et al.
Publicado: (2022)

Inhaled milrinone for sick COVID-19 cohort: A pathophysiology driven hypothesis!
por: Magoon, Rohan, et al.
Publicado: (2021)

Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid
por: Maki, Takakuni, et al.
Publicado: (2014)

Milrinone role in treatment of septic shock
por: Tomicic, V, et al.
Publicado: (2015)

Milrinone: Treatment failure: case report
Publicado: (2020)

Milrinone, we all like you …
por: Januszewska, Katarzyna
Publicado: (2023)

Metabolic effects of phosphodiesterase III inhibitors: another reason to promote their use?
por: Simkova, Vladislava, et al.
Publicado: (2007)

Milrinone in Enterovirus 71 Brain Stem Encephalitis
por: Wang, Shih-Min
Publicado: (2016)

Continuous Intravenous Milrinone Therapy in Pediatric Outpatients
por: Curley, Michelle, et al.
Publicado: (2017)

Milrinone Relaxes Pulmonary Veins in Guinea Pigs and Humans
por: Rieg, Annette D., et al.
Publicado: (2014)

Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
por: Lyhne, Mads D., et al.
Publicado: (2021)

Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients
por: Ikumi, Kyoko, et al.
Publicado: (2021)

The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis
por: Del Rio-Pertuz, Gaspar, et al.
Publicado: (2023)

Milrinone/nitric-oxide: Lack of efficacy: case report
Publicado: (2021)

Successful Management of Hemodynamically Unstable Takotsubo Cardiomyopathy With Milrinone
por: Pahuja, Karan H, et al.
Publicado: (2022)

Unanticipated severe pulmonary hypertension in a patient undergoing living donor liver transplant - Role of milrinone and transesophageal echocardiography
por: Sindwani, Gaurav, et al.
Publicado: (2021)

Phosphodiesterase-5 Inhibitors as Therapeutics for Cardiovascular Diseases: A Brief Review
por: Corbic, Milena, et al.
Publicado: (2023)

Rolipram: Eotaxin and phosphodiesterase IV inhibitor versus bronchial hyper-reactivity response
por: Khan, Hamza Hassan, et al.
Publicado: (2015)

Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors
por: Masadeh, Majed M., et al.
Publicado: (2014)

Phosphodiesterase type 5 inhibitor to riociguat transition is associated with hemodynamic and symptomatic improvement in pulmonary hypertension
por: Davey, Ryan, et al.
Publicado: (2017)

Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression
por: Schmittinger, Christian A, et al.
Publicado: (2008)

Milrinone Attenuates Arteriolar Vasoconstriction and Capillary Perfusion Deficits on Endotoxemic Hamsters
por: de Miranda, Marcos Lopes, et al.
Publicado: (2015)

Correction: Milrinone Relaxes Pulmonary Veins in Guinea Pigs and Humans
Publicado: (2014)

Repetitive milrinone therapy in ambulatory advanced heart failure patients
por: Laufer‐Perl, Michal, et al.
Publicado: (2022)

Inhaled milrinone in cardiac surgical patients: pharmacokinetic and pharmacodynamic exploration
por: Nguyen, Anne Quynh-Nhu, et al.
Publicado: (2023)

Prevalence of Phosphodiesterase-5 Inhibitor Use in the VHA in 2004 and 2005 Is Twice That of a Commercial Health Plan in 2001
por: French, Dustin D., et al.
Publicado: (2006)

Evolution of Phosphodiesterase-5 Inhibitors
por: Moon, Du Geon
Publicado: (2015)

Effect of phosphodiesterase inhibitors in the bladder
por: Chughtai, Bilal, et al.
Publicado: (2015)

Lipoxin A4 as a possible mediator of the beneficial actions of phosphodiesterase-5 enzyme inhibitors
por: Das, Undurti N.
Publicado: (2016)

Extended‐Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Nanayakkara, Shane, et al.
Publicado: (2020)

Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts
por: Matsumoto, Shuhei, et al.
Publicado: (2012)

Patient Attributes Associated With Better Long-Term Outcomes on Palliative Milrinone
por: Sharma, Toishi, et al.
Publicado: (2020)

Milrinone effects on cardiac mitochondria, hemodynamics, and death in catecholamine-infused rats
por: Lin, I-Chun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_obkmpiti16125fmrtebs32b3gu